Skip to main content

Table 1 Comparison of the working system for lung cancer trials among 3 institutes

From: Insight into early-phase trials for lung cancer in the United States

Item

GLCI

MDACC

UWCCC

Department

Pulmonary Oncology

Thoracic Head and Neck Medical Oncology

Thoracic Head and Neck Medical Oncology

Physicians

Medical, surgical, and radiation oncologists

Medical oncologists

Medical oncologists

Multidisciplinary clinic

No

No

Yes

Multidisciplinary conference

Yes

Yes

Yes

Grand roundsa

No

Yes

Yes

Working group meeting for trials

Every 2–3 weeks

Weekly

Weekly

PRMC meeting

No

Yes, monthly

Yes, biweekly

Molecular tumor board or discussion and strategies for incorporation of molecular characteristics

No

No

Yes

Academic discussion about translational medicine of lung cancer

Monthly

No

No

Clinical trials in September 2014

 

Not available

 

 Phase 1

3

 

8

 Phase 2

4

 

8

 Phase 3

4

 

4

 Others

7

 

3

Clinical trials in December 2014

  

Not available

 Phase 1

5

28

 

 Phase 2

5

15

 

 Phase 3

4

3

 

 Others

7

1

 
  1. GLCI Guangdong Lung Cancer Institute, MDACC MD Anderson Cancer Center, UWCCC University of Wisconsin Carbone Cancer Center, PRMC protocol review and monitoring committee.
  2. aGrand Round refers to an academic lecture formally given by a specialist, expert, professor, scientist, or occasionally, a PhD student who is within a hospital/institute/university or from outside.